Latest article
Poxel’s Diabetes Drug Wins Japan Nod, However Competitors Stays Fierce
As the French biotech company Poxel marks the first approval of its oral type 2 diabetes drug in Japan, the future of this drug...
The diabetes ‘treatment’ Vertex acquired in its 2019 Semma buyout? It’s headed to the...
The stem cell-derived therapy at the center of Vertex's $ 950 million...
Diabetes-Covid-steroids combine inflicting improve in fungal infections: Docs | Pune Information
Pune: A combination of diabetes, Covid-19, and a unified approach to steroid use has led to an increase in invasive fungal infections during the...